Latest News

Matt Kapusta, MBA  (Credit: uniQure)
FDA Grants Regenerative Medicine Advanced Therapy Designation for AMT-130 Gene Therapy in Huntington Disease

June 16th 2024

AMT-130, uniQure’s investigational gene therapy, is the first therapeutic candidate to receive regenerative medicine advanced therapy designation for Huntington disease.

NeurologyLive® Brain Games: June 16, 2024
NeurologyLive® Brain Games: June 16, 2024

June 16th 2024

Therapeutic Potential of Orexin Agonist ALKS 2680 on Display at SLEEP 2024
Therapeutic Potential of Orexin Agonist ALKS 2680 on Display at SLEEP 2024

June 15th 2024

Reaction and Ramifications of Deutetrabenazine One Pill, Once-Daily Tablet Approval
Reaction and Ramifications of Deutetrabenazine One Pill, Once-Daily Tablet Approval

June 15th 2024

NeurologyLive® Friday 5 — June 14, 2024
NeurologyLive® Friday 5 — June 14, 2024

June 14th 2024

Coverage of SLEEP 2024

Get the latest data and clinical news updates, as well as interviews with experts, straight from the conference floor of SLEEP 2024.

SLEEP 2024

Conference Coverage

View All
Therapeutic Potential of Orexin Agonist ALKS 2680 on Display at SLEEP 2024
Therapeutic Potential of Orexin Agonist ALKS 2680 on Display at SLEEP 2024

June 15th 2024

Episode 117: 2024 Consortium of Multiple Sclerosis Centers Annual Meeting Highlights
Episode 117: 2024 Consortium of Multiple Sclerosis Centers Annual Meeting Highlights

June 14th 2024

Sanjay R. Patel, MD, MS
Promising Developments in Pharmaceutical Treatments for Sleep Apnea: Sanjay R. Patel, MD, MS

June 13th 2024

Using the Cionic Neural Sleeve to Alleviate Gait Dysfunction in Multiple Sclerosis: Douglas A. Wajda, PhD
Using the Cionic Neural Sleeve to Alleviate Gait Dysfunction in Multiple Sclerosis: Douglas A. Wajda, PhD

June 13th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.